REMOVAL OF BABOON AND HUMAN ANTIPORCINE IGG AND IGM NATURAL ANTIBODIES BY IMMUNOADSORPTION - RESULTS OF IN-VITRO AND IN-VIVO STUDIES

被引:116
作者
LEVENTHAL, JR
JOHN, R
FRYER, JP
WITSON, JC
DERLICH, JM
REMISZEWSKI, J
DALMASSO, AP
MATAS, AJ
BOLMAN, RM
机构
[1] BAXTER HEALTHCARE CORP,DIV RENAL,MINNEAPOLIS,MN
[2] BAXTER HEALTHCARE CORP,DIV IMMUNOTHERAPY,MINNEAPOLIS,MN
关键词
D O I
10.1097/00007890-199501270-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The safe and effective removal of xenoreactive antibodies in the peritransplant period is Likely to be critical for the clinical application of xenotransplantation involving disparate donor species, such as the pig, In an effort to develop an improved method for antibody removal in xenotransplantation, we have studied reusable antihuman antibody (Ig) columns in vitro and in vivo. Two types of columns were tested: (1) an antihuman Ig column containing polyclonal sheep antihuman IgG (heavy- and light-chain-specific) conjugated to sepharose CL-4B (Ig-Therasorb), and (2) an antihuman Ig column using polyclonal antihuman IgM (mu chain-specific) conjugated to sepharose, Passage of human or baboon plasma through the Ig-Therasorb column resulted in 97.5% and 78.4% mean reductions in total IgG and IgM, respectively, Reductions in total IgG and IgM correlated with lowering of antipig IgG (54-486 fold) and IgM (9-54 fold) antibody titers as assessed by pig endothelial cell ELISA. The ability of the Ig-Therasorb to significantly reduce IgM may be attributed to the light chain specificity of this column. With the anti-IgM column, marked reductions in total (82.6-83.9%) and antipig (27-54 fold) IgM in human and baboon plasma occurred, while levels of total and xenoreactive IgG were slightly affected. Other than a dilutional effect, neither column resulted in significant reduction in albumin, fibrinogen, factor 5, and factor 8, Repeated in vivo use of either column in baboons achieved reductions in IgG and IgM that closely followed the results of our in vitro studies. No subject morbidity or mortality occurred. Use of the Ig-Therasorb column with immunosuppression in two baboons receiving pig renal xenografts achieved sustained reductions in antipig antibodies and prevented hyperacute rejection, Subjects were sacrificed at 11 and 13 days posttransplant with functioning xenografts and were found to have no evidence of vascular xenograft rejection, We conclude that anti Ig columns represent a safe and effective method for antibody removal, without several of the limitations of other antibody removal techniques. Also, columns appear to be safe for repeated antibody removal in the posttransplant period.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 22 条
  • [1] ALEXANDRE GPJ, 1989, XENOGRAFT, V25, P259
  • [2] XENOGENEIC TRANSPLANTATION - A REVIEW
    AUCHINCLOSS, H
    [J]. TRANSPLANTATION, 1988, 46 (01) : 1 - 20
  • [4] COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238
  • [5] DUMOULIN A, 1990, TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN THE PREVENTION OF CORONARY HEART DISEASE 2, P170
  • [6] ANTIBODY-BASED IMMUNOADSORPTION AS A THERAPEUTIC MEANS
    DUMOULIN, A
    MULLERDERLICH, J
    BIEBER, F
    RICHTER, WO
    FREI, U
    MULLER, R
    SPAETHE, R
    [J]. BLOOD PURIFICATION, 1993, 11 (03) : 145 - 149
  • [7] FISCHEL RJ, 1991, TRANSPLANT P, V23, P589
  • [8] KABAT EA, 1961, EXPERIMENTAL IMMUNOC, P149
  • [9] LEVENTHAL JR, 1994, TRANSPLANTATION, V57, P974
  • [10] PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL BY DEPLETION OF COMPLEMENT
    LEVENTHAL, JR
    DALMASSO, AP
    CROMWELL, JW
    PLATT, JL
    MANIVEL, CJ
    BOLMAN, RM
    MATAS, AJ
    BACH
    ZUKOSKI
    BAUMGARTNER
    [J]. TRANSPLANTATION, 1993, 55 (04) : 857 - 866